The CYP1A2 -163C>A polymorphism does not alter the effects of caffeine on basketball performance
Puente C, Abián-Vicén J, Del Coso J, Lara B, Salinero JJ
PloS one · 40 citas
Cómo se estudió
- Diseño
- Ensayo controlado aleatorizado (clasificado por nuestro filtro de IA)
- Estudiado en
- Personas
- Resultado principal
- Marcadores de salud y funcionamiento
Quién lo pagó
- Financiación
- Financiación independiente
- Universidad u hospital
- Vice Rectorate of Science, Camilo José Cela University
Según 1 financiador declarado y la declaración de financiación del texto completo.
Publicación
- Publicado
- 2018-04-18 · PLoS One · vol. 13 · número 4 · pág. e0195943
- Editorial
- Public Library of Science
- Citado
- 56 citas · más que el 96% de estudios similares · 4.8× el promedio de su campo
- Impacto
- Entre el 10 % más citado de su campo
- Referencias
- 35 trabajos
- Acceso
- Acceso abierto (revista) · CC-BY
- Áreas de investigación
- Coffee research and impacts · Genetics and Physical Performance · Muscle metabolism and nutrition
- Palabras clave
- Basketball, Caffeine, Allele, Genotype, CYP1A2, Sprint, Polymorphism (computer science), Medicine, Internal medicine, Genetics, Psychology, Biology, Physical therapy, Metabolism, Gene
- MeSH
- humans, caffeine, cytochrome p-450 cyp1a2, pharmacogenetics, genotype, polymorphism, single nucleotide, alleles, basketball, adult, female, male, athletic performance, young adult, genetic association studies, pharmacogenomic variants
5 autores
- Carlos Puente🇪🇸Camilo José Cela University
- Javier Abián‐Vicén🇪🇸Camilo José Cela University; University of Castilla-La Mancha
- Juan Del Coso🇪🇸 · autor de correspondenciaCamilo José Cela University
- Beatriz Lara🇪🇸Camilo José Cela University
- Juan José Salinero🇪🇸Camilo José Cela University
Resumen
El texto original del estudio, en el idioma en que se publicó.
Purpose
The aim of this investigation was to analyze the influence of the genetic variations of the -163C>A polymorphism of the CYP1A2 gene on the ergogenic effects of caffeine in elite basketball players.
Methods
Nineteen elite basketball players (10 men and 9 women) ingested 3 mg⋅kg-1 of caffeine or a placebo 60 min before performing 10 repetitions of the following series: the Abalakov jump test followed by the Change-of-Direction and Acceleration Test (CODAT). The players then competed in a 20-min simulated basketball game. Self-perceived performance and side effects were recorded by questionnaires after the trials. The effects of caffeine on basketball performance were established according to players' CYP1A2 genotype (rs762551): AA homozygotes (n = 10) and C-allele carriers (n = 9).
Results
In the 10 repetitions, caffeine increased Abalakov jump height by a mean of 2.9±3.6% in AA homozygotes (p = 0.03) while this effect did not reach statistical significance for C-allele carriers (2.3 ± 6.8%; p = 0.33). Caffeine did not affect sprint time in the CODAT test in either genotype group but it increased the number of impacts performed during the simulated game in both AA homozygotes (4.1 ± 5.3%; p = 0.02) and C-allele carriers (3.3 ± 3.2%; p = 0.01). During the 24 h following the test, AA homozygotes tended to experience increased insomnia with caffeine while C-allele carriers did not present this effect. The remaining variables were unaffected by the genotype.
Conclusion
The CYP1A2 -163C>A polymorphism minimally altered the ergogenicity derived from the consumption of a moderate dose of caffeine in elite basketball players.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY).
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.